Steik Jason Paul (CIK 2078374) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-10). Recent activity: Sell PNTG (1,394 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | Pennant Group, Inc. (PNTG) | Chief Clinical Officer | Sell | 1,394 | $53,700 |
Source: SEC Form 4 filings · as of 2026-08-10